Azopharma Product Development Group and ACCU-BREAK Pharmaceuticals, Inc. Announce Strategic Alliance Partnership

Published: Jan 18, 2008

MIRAMAR & PLANTATION, Fla.--(BUSINESS WIRE)--Privately-held Azopharma Product Development Group, Inc. (“Azopharma”) and ACCU-BREAK Pharmaceuticals, Inc. (“ABP”) announced today the signing of a strategic alliance agreement in which Azopharma will become the “center of excellence” for developing products based on ABP’s innovative ACCU-BREAK™ patented tablet technologies which allow for accurate and individualized dosage adjustment.

Back to news